BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 11221919)

  • 21. Immunohistochemical characterization of the leucocytic infiltrate associated with canine seminomas.
    Grieco V; Rondena M; Romussi S; Stefanello D; Finazzi M
    J Comp Pathol; 2004 May; 130(4):278-84. PubMed ID: 15053930
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Expression of MAGE genes in testicular germ cell tumors.
    Hara I; Hara S; Miyake H; Yamanaka K; Nagai H; Gohji K; Arakawa S; Kamidono S
    Urology; 1999 Apr; 53(4):843-7. PubMed ID: 10197872
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Molecular staging of testicular cancer using polymerase chain reaction of the testicular cancer-specific genes].
    Nonomura N; Imazu T; Harada Y; Nozawa M; Ono Y; Fukui T; Nishimura K; Okuyama A
    Hinyokika Kiyo; 1999 Aug; 45(8):593-7. PubMed ID: 10500969
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Redirecting human CD4+ T lymphocytes to the MHC class I-restricted melanoma antigen MAGE-A1 by TCR alphabeta gene transfer requires CD8alpha.
    Willemsen R; Ronteltap C; Heuveling M; Debets R; Bolhuis R
    Gene Ther; 2005 Jan; 12(2):140-6. PubMed ID: 15496961
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Expression of MAGE tumour-associated antigens is inversely correlated with tumour differentiation in invasive ductal breast cancers: an immunohistochemical study.
    Kavalar R; Sarcevic B; Spagnoli GC; Separovic V; Samija M; Terracciano L; Heberer M; Juretic A
    Virchows Arch; 2001 Aug; 439(2):127-31. PubMed ID: 11561752
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Morphometrical quantification of spermatogonial germ cells with the 57B anti-MAGE-A4 antibody in the evaluation of testicular biopsies for azoospermia.
    Yakirevich E; Sabo E; Dirnfeld M; Sova Y; Spagnoli GC; Resnick MB
    Appl Immunohistochem Mol Morphol; 2003 Mar; 11(1):37-44. PubMed ID: 12610355
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Expression of the MAGE gene family in human lymphocytic leukemia.
    Shichijo S; Tsunosue R; Masuoka K; Natori H; Tamai M; Miyajima J; Sagawa K; Itoh K
    Cancer Immunol Immunother; 1995 Aug; 41(2):90-103. PubMed ID: 7656275
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Tissue microarray evaluation of Melanoma antigen E (MAGE) tumor-associated antigen expression: potential indications for specific immunotherapy and prognostic relevance in squamous cell lung carcinoma.
    Bolli M; Kocher T; Adamina M; Guller U; Dalquen P; Haas P; Mirlacher M; Gambazzi F; Harder F; Heberer M; Sauter G; Spagnoli GC
    Ann Surg; 2002 Dec; 236(6):785-93; discussion 793. PubMed ID: 12454517
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Residual tumor micro-foci and overwhelming regulatory T lymphocyte infiltration are the causes of bladder cancer recurrence.
    Parodi A; Traverso P; Kalli F; Conteduca G; Tardito S; Curto M; Grillo F; Mastracci L; Bernardi C; Nasi G; Minaglia F; Simonato A; Carmignani G; Ferrera F; Fenoglio D; Filaci G
    Oncotarget; 2016 Feb; 7(6):6424-35. PubMed ID: 26824503
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Testicular seminoma: a clinicopathologic and immunohistochemical study of 105 cases with special reference to seminomas with atypical features.
    Tickoo SK; Hutchinson B; Bacik J; Mazumdar M; Motzer RJ; Bajorin DF; Bosl GJ; Reuter VE
    Int J Surg Pathol; 2002 Jan; 10(1):23-32. PubMed ID: 11927966
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Involvement of the Fas/FasL pathway in the pathogenesis of germ cell tumours of the adult testis.
    Kersemaekers AM; van Weeren PC; Oosterhuis JW; Looijenga LH
    J Pathol; 2002 Apr; 196(4):423-9. PubMed ID: 11920738
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Primary mediastinal seminomas: a comprehensive immunohistochemical study with a focus on novel markers.
    Weissferdt A; Rodriguez-Canales J; Liu H; Fujimoto J; Wistuba II; Moran CA
    Hum Pathol; 2015 Mar; 46(3):376-83. PubMed ID: 25576290
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Ex vivo characterization of tumor-derived melanoma antigen encoding gene-specific CD8+cells in patients with hepatocellular carcinoma.
    Zerbini A; Pilli M; Soliani P; Ziegler S; Pelosi G; Orlandini A; Cavallo C; Uggeri J; Scandroglio R; Crafa P; Spagnoli GC; Ferrari C; Missale G
    J Hepatol; 2004 Jan; 40(1):102-9. PubMed ID: 14672620
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A MAGE-6-encoded peptide is recognized by expanded lymphocytes infiltrating a spontaneously regressing human primary melanoma lesion.
    Zorn E; Hercend T
    Eur J Immunol; 1999 Feb; 29(2):602-7. PubMed ID: 10064076
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Lack of terminally differentiated tumor-specific CD8+ T cells at tumor site in spite of antitumor immunity to self-antigens in human metastatic melanoma.
    Mortarini R; Piris A; Maurichi A; Molla A; Bersani I; Bono A; Bartoli C; Santinami M; Lombardo C; Ravagnani F; Cascinelli N; Parmiani G; Anichini A
    Cancer Res; 2003 May; 63(10):2535-45. PubMed ID: 12750277
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Heterogeneity of melanoma antigen-1 (MAGE-1) gene and protein expression in malignant melanoma.
    Zuber M; Spagnoli GC; Kocher T; Lüscher U; Schaefer C; Noppen C; Gudat F; Harder F; Heberer M
    Eur Surg Res; 1997; 29(5):403-10. PubMed ID: 9323494
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Direct selection of a human antibody fragment directed against the tumor T-cell epitope HLA-A1-MAGE-A1 from a nonimmunized phage-Fab library.
    Chames P; Hufton SE; Coulie PG; Uchanska-Ziegler B; Hoogenboom HR
    Proc Natl Acad Sci U S A; 2000 Jul; 97(14):7969-74. PubMed ID: 10884427
    [TBL] [Abstract][Full Text] [Related]  

  • 38. MAGE-3 immunoreactivity in formalin-fixed, paraffin-embedded primary and metastatic melanoma: frequency and distribution.
    Hofbauer GF; Schaefer C; Noppen C; Böni R; Kamarashev J; Nestle FO; Spagnoli GC; Dummer R
    Am J Pathol; 1997 Dec; 151(6):1549-53. PubMed ID: 9403705
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Heterogeneity of T-cell clones infiltrating primary malignant melanomas.
    Yazdi AS; Morstedt K; Puchta U; Ghoreschi K; Flaig MJ; Rocken M; Sander CA
    J Invest Dermatol; 2006 Feb; 126(2):393-8. PubMed ID: 16374454
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Construction and binding analysis of recombinant single-chain TCR derived from tumor-infiltrating lymphocytes and a cytotoxic T lymphocyte clone directed against MAGE-1.
    Lake DF; Salgaller ML; van der Bruggen P; Bernstein RM; Marchalonis JJ
    Int Immunol; 1999 May; 11(5):745-51. PubMed ID: 10330280
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.